Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature.
Fusco V, Porta C, Saia G, Paglino C, Bettini G, Scoletta M, Bonacina R, Vescovi P, Merigo E, Lo Re G, Guglielmini P, Di Fede O, Campisi G, Bedogni A. Fusco V, et al. Clin Genitourin Cancer. 2015 Aug;13(4):287-294. doi: 10.1016/j.clgc.2014.12.002. Epub 2014 Dec 9. Clin Genitourin Cancer. 2015. PMID: 25586958 Review.
Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
Fusco V, Baraldi A, Loidoris A, Ciuffreda L, Galassi C, Goia F, Scoletta M, Berrone S, Benech A, Ortega C, Berruti A; Rete Oncologia di Piemonte e Valle d'Aosta ONJ Study Group. Fusco V, et al. J Oral Maxillofac Surg. 2009 Aug;67(8):1775. doi: 10.1016/j.joms.2009.03.061. J Oral Maxillofac Surg. 2009. PMID: 19615599 No abstract available.
Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study.
Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E, Solazzo L, Gabriele M, Gaeta GM, Favia G, Peluso F, Colella G. Vescovi P, et al. Among authors: fusco v. Oral Oncol. 2011 Mar;47(3):191-4. doi: 10.1016/j.oraloncology.2010.11.007. Epub 2011 Feb 2. Oral Oncol. 2011. PMID: 21292541
Prevention of bisphosphonates-induced osteonecrosis.
Baraldi A, Fusco V, Bellora A, Pini M. Baraldi A, et al. Among authors: fusco v. Clin Cases Miner Bone Metab. 2007 Jan;4(1):58-61. Clin Cases Miner Bone Metab. 2007. PMID: 22460755 Free PMC article.
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.
Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group. Lapi F, et al. Among authors: fusco v. Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y. Epub 2012 May 23. Osteoporos Int. 2013. PMID: 22618266
Decreasing frequency of osteonecrosis of the jaw in cancer and myeloma patients treated with bisphosphonates: the experience of the oncology network of piedmont and aosta valley (north-Western Italy).
Fusco V, Galassi C, Berruti A, Ortega C, Ciuffreda L, Scoletta M, Goia F, Migliario M, Baraldi A, Boccadoro M, Loidoris A, Bertetto O. Fusco V, et al. ISRN Oncol. 2013;2013:672027. doi: 10.1155/2013/672027. Epub 2013 Feb 27. ISRN Oncol. 2013. PMID: 23533811 Free PMC article.
234 results